ABVC BioPharma dismisses Simon & Edward, engages Kreit & Chiu CPA as new auditor

ABVC BIOPHARMA, INC.

Audit committee dismissed Simon & Edward, LLP on June 30, 2026; engaged Kreit & Chiu CPA LLP for FY 2026.
S&E's reports for FY 2024 and 2025 contained no adverse opinion except a going concern explanatory paragraph.
No disagreements with S&E on accounting principles or audit scope during the two most recent fiscal years.
Previously disclosed material weaknesses in internal control over financial reporting were the only reportable events.
S&E provided a letter to the SEC agreeing with the disclosures, filed as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.